medigraphic.com

2014, Número 2

<< Anterior Siguiente >>

Rev Cuba Endoc 2014; 25 (2)


Algunos procedimientos endoluminales para el tratamiento de la obesidad

Hernández RJ, Licea PME, Castelo Elías-Calles L

Idioma: Español
Referencias bibliográficas: 74
Paginas: 104-123
Archivo PDF: 277.14 Kb.


RESUMEN

El tratamiento de la obesidad está signado por múltiples caminos terapéuticos, y el avance tecnológico ha permitido el desarrollo de técnicas de tipo restrictivas, de carácter funcional y mecánico, así como otras de tipo malabsortivas, las cuales se comportan de forma poco agresivas, en comparación con las empleadas en la cirugía bariátrica convencional, y que por sus resultados alentadores comienzan a tener aceptación. En el artículo se describen algunos de los procedimientos endoluminales para el tratamiento de la obesidad. Se hace mención a las indicaciones generales de este tratamiento, sus mecanismos de acción y posibles contraindicaciones, así como su utilidad, pero se enfatiza que su elección debe ser individualizada, en función de lograr resultados deseables, y en relación con las características del paciente.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. OMS. Obesidad y sobrepeso. Nota descriptiva N° 311 [homepage en Internet]; Mayo de 2012 [citado 5 de octubre de 2013]. Disponible en: http://www.who.int/mediacentre/factsheets/fs311/es/index.html

  2. Araya V. Obesity-current and future epidemiology. Medwave. 2010;10(03):e4443.

  3. Escribano S, Vega AT, Lozano J, Lamo RA, Lleras S, Castrodeza J, et al. Patrón epidemiológico de la obesidad en Castilla y León y su relación con otros factores de riesgo de enfermedad cardiovascular. Rev Esp Cardiol. 2011;64(1):636.

  4. Mazure RA, Breton I, Cancer E, Mellado C, Abilés V, Avilés J, et al. Balón intragástrico en el tratamiento de la obesidad. Nutr Hosp. 2009;24(2):138-43.

  5. Romero A, Montori V, López F. Índice de masa corporal y mortalidad. Rev Esp Cardiol. 2011;64(1):63-6.

  6. Van Gemer WG, Adang EM, Greve JW, Soeters PB. Quality of live assessment of morbidly obese patients: effect of weight reducting surgery. Am J Clin Nutr. 1998;67(2):197-201.

  7. Córdova JÁ. El Acuerdo Nacional para la Salud Alimentaria como una estrategia contra el sobrepeso y la obesidad. Cir Cir. 2010;78:105-7.

  8. Bahia L, Coutinho ES, Barufaldi LA, de Azevedo G, Malhão TA, de Souza CP, et al. The costs of over-weight and obesity related diseases in the Brazilian public health system: cross sectional study. BMC Public Health. 2012;12:440.

  9. Trogdon JG, Finkelstein EA, Hylands T, Dellea PS, Kamal-Bahl SJ. Indirect costs of obesity: a review of the current literature Obesity Rev. 2008;9:489-500.

  10. Bell JF, Zimmerman FJ, Arterburn DE, Maciejewski ML. Health care expenditures of overweight and obese males and females in the medical expenditures panel survey by age cohort. Obesity. 2011;19:228-32.

  11. Vojvodic I. Cuestionamientos a la Cirugía Bariátrica. Rev Gastroenterol Perú. 2009;29(4):355-61.

  12. Cánovas B, Sastre J, Moreno G, Llamazares O, Familiar C, Abad S, et al. Comparación de resultados previos y posteriores a la aplicación de un protocolo de actuación en cirugía bariátrica. Nutr Hosp. Feb 2011;26(1):116-21.

  13. ASGE Technology Committee, Kethu SR, Banerjee S, Barth BA, Desilets DJ, Kaul V, et al. Endoluminal bariatric techniques. Gastrointest Endosc. 2012;76(1):1-7.

  14. Espinet E, Nebreda J, Gómez JA, Muñoz M, Pujol J, Vila C, et al. Técnicas endoscópicas actuales en el tratamiento de la obesidad. Rev Esp Enferm Dig. 2012;104:72-87.

  15. Martínez AJ, Aliaga A, Pereira JL, Jiménez I, Romero AR, Sobrino S, et al. Procedimientos endoluminales/endoscópicos en el tratamiento de la obesidad. Endocrinología y Nutrición. 61(5):264-73.

  16. Swidnicka-Siergiejko A, Wróblewski E, Dabrowski A. Endoscopic treatment of obesity. Can J Gastroenterol. Nov 2011;25(11):627-33.

  17. Chen JDZ, Yin J, McCallum RW. Gastric Electrical Stimulation for Gastroparesis. In: Parkman HP, McCallum RW, eds. Gastroparesis. Pathophysiology, presentation and treatment. Texas: Humana Press; 2012. p. 353-64.

  18. Cáncer E, Abilés V, Abilés J, Martínez MA, Bretón I, Peláez N, et al. Técnicas mínimamente invasivas emergentes en el tratamiento de la obesidad. Nutr Hosp. Ago 2012;27(4):1025-30.

  19. Zhang J, Tang M, Chen JDZ. Gastric Electrical Stimulation for Obesity: The Need for a New Device Using Wider Pulses. Obesity. 2008;17:47480.

  20. Zhang J, Maude-Griffin R, Zhu H, Sun Y, Starkebaum W, Firestone E. Gastric electrical stimulation parameter dependently alters ventral medial hypothalamic activity and feeding in obese rats. AJP-GI. 2011;301(5):G912-G918.

  21. Escalona A. Aplicaciones de NOTES en cirugía bariátrica. Cirugía Endoscópica. Ene-Mar 2009;10(1):27-32.

  22. Shikora SA, Bessler M, Fisher BL, Trigilio C, Moncure M, Greenstein R. Laparoscopic insertion of the Implantable gastric stimulator (IGStm): initial surgical experience. Obes Surg. 2000;10:315.

  23. Liu J, Hou X, Song G, Cha H, Yang B, Chen JD. Gastric electrical stimulation using endoscopically placed mucosal electrodes reduces food intake in humans. Am J Gastroenterol. 2006;101(4):798-803.

  24. Cigaina V, Pinato G, Rigo V, Bevilacqua M, Ferraro F, Ischia S, et al. Gastric peristalsis control by mono situ electric stimulation: a preliminary study. Obes Surg. 1996;6:247-9.

  25. Cigaina V. Gastric pacing as therapy for morbid obesity: preliminary results. Obes Surg. 2002;12:12S-16S.

  26. Shikora SA, Bergenstal R, Bessler M, Brody F, Foster G, Frank A, et al. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis. January 2009;5(1):31-7.

  27. Bohdalian A, Ludvik B, Guerci B, Bresler L, Renard E, Nocca D, et al. Improvement in glycemic control by gastric electrical stimulation (TANTA-LUS) in overweight subjects with type 2 diabetes. Surg Endosc. 2009;23:1955-60.

  28. Sanmiguel CP, Conklin JL, Cunneen SA, Barnett P, Phillips EH, Kipnes M, et al. Gastric Electrical Stimulation with the TANTALUS® System in Obese Type 2 Diabetes Patients: Effect on Weight and Glycemic Control. J Diabetes Sci Technol. 2009 July;3(4):964-70.

  29. Bohdjalian A, Prager G, Rosak C, Weiner R, Jung R, Schramm M, et al. Improvement in Glycemic Control in Morbidly Obese Type 2 Diabetic Subjects by Gastric Stimulation. Obesity Surgery. Sept 2009;19(9):1221-7.

  30. Zhao X, Yin J, Chen J, Song G, Wang L, Zhu H, et al. Inhibitory effects and mechanisms of intestinal electrical stimulation on gastric tone, antral contractions, pyloric tone, and gastric emptying in dogs. American Journal of Physiology- Regulatory, Integrative and Comparative Physiology. 2009;296:R36-R42.

  31. Sallam HS, Chen JDZ. Colon Electrical Stimulation: Potential Use for Treatment of Obesity. Obesity. 2011;19:1761-7.

  32. Gui D, Mingrone G, Valenza V, Spada PL, Mutignani M, Runfola M. Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study. Aliment Pharmacol Ther. 2006;1(23):675-80.

  33. Mittermair R, Keller C, Geibel J. Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg. 2007;17:732-6.

  34. Júnior AC, Savassi-Rocha PR, Coelho LG, Spósito MM, Albuquerque W, Diniz MT. Botulinum A toxin injected into the gastric wall for the treatment of class III obesity: a pilot study. Obes Surg. 2006;16:335-43.

  35. Foschi D, Corsi F, Lazzaroni M, Sangaletti O, Riva P, La Tartara G, et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Intern J Obes. 2007;31:707-12.

  36. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, et al. Endoscopic Ultrasound-Guided Gastric Botulinum Toxin Injections in Obese Subjects: A Pilot Study. Obesity Surgery. April 2008;18(4):401-7.

  37. Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;1:198-9.

  38. Pasulka PS, Bistrian BR, Benotti PN. The risks of surgery in obese patients. Ann Intern Med. 1986 Apr;104(4):540-6.

  39. Roberta Maselli AG. Il ruolo dell'endoscopia nella terapia dell'obesità. Giorn Ital End Dig. 2011;34:91-6.

  40. Kethu SR, Banerjee S, Barth BA, Desilets DJ, Kaul V, ASGE Technology Committee, et al. Endoluminal bariatric techniques. Gastrointest Endosc. 2012 Jul;76(1):1-7.

  41. Jenkins JT, Galloway DJ. A simple novel technique for intragastric balloon retrieval. Obes Surg. 2005;15(1):122-4.

  42. Genco A, Bruni T, Doldi SB, Forestieri P, Marino M, Busetto L, et al. Bio Enterics Intragastric Balloon: The Italian Experience with 2,515 Patients. Obes Surg. 2005:1161-4.

  43. Escudero A, Catalán I, Gonzalvo J, Bixquert M, Navarro L, Herrera L, et al. Efectividad, seguridad y tolerancia del balón intragástrico asociado a una dieta hipocalórica para la reducción de peso en pacientes obesos. Rev Esp Enferm Dig. 2008;100(6):349-54.

  44. Escalona A. Aplicaciones de NOTES en cirugía bariátrica. Cirugía Endoscópica. Ene-Mar 2009;10(1):27-32.

  45. López G, Rubio MA, Prados S, Pastor G, Cruz MR, Companioni E, et al. Bio Enterics Intragastric Balloon (BIB). Single ambulatory Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2011;1(1):5-9.

  46. Genco A, Cipriano M, Bacci V, Maselli R, Paone E, Lorenzo M, et al. Intragastric balloon followed by diet vsintragastric balloon followed by another balloon: a prospective study on 100 patients. Obes Surg. 2010;20(11):1496-500.

  47. Días C, González O, Landaeta J, Velásquez R, Segnini I, Aponte L, et al. Segundo Balón Intragástrico para el Tratamiento de la Obesidad: Experiencia Preliminar. GEN. Sept 2012;66(3):173-7.

  48. Sciumè C, Geraci G, Pisillo F, Arnone E, Mortillaro M, Modica G. Role of intragastric air filled balloon (Heliosphere bag) in severe obesity. Personal experience. Ann Ital Chir. 2009;80(2):113-7.

  49. Trande P, Mussetto A, Mirante VG, De Martines E, Olivetti G, Conigliaro RL, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg. 2010;20(9):1227-30.

  50. Lecumberri E, Krekshi W, Matía P, Hermida C, De la Torre NG, Cabrerizo L, et al. Effectiveness and safety of air-filled Balloon Heliosphere BAG in 82 consecutive obese patients. Obes Surg. 2011;21(10):1508-12.

  51. Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen L, Gostout C, et al. Adjustable Intragastric Balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011;21(10):1499-507.

  52. Gaggioti G, Tack J, Garrido AB Jr., Palau M, Cappelluti G, Di Matteo F. Adjustable totally implantable intragastric prosthesis (ATIIP)-Endogast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey. Obes Surg. 2007;17(7):949-56.

  53. De Jong K, Mathus-Vliegen EM, Velchuyzen EA, Eshuis JH, Fockens P. Shortterm safety and efficacy of the trans-oral endoscopic restrictive implant system for the treatment of obesity. Gastrointest Endosc. 2010;71:978-82.

  54. Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008;68:51-8.

  55. Talarico JA, Brethauer SA, Schauer PhR. Primary Endoluminal Techniques for Weight Loss. In: Christopher C. Thompson. Bariatric Endoscopy. Cap 19. New York: Publisher Springer; 2013. p. 195-204.

  56. Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis. 2010;6(6):689-94.

  57. Moreno C, Closset J, Dugardeyn S, Baréa M, Mehdi A, Collignon L, et al. Transoralgastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy. 2008;40(5):406-13.

  58. Thompson CC, Brethauer SA, Chand B, DB Lautz, Kaplan LM, Schauer PR. M1259 Transoral Gastric Volume Reduction as an Intervention for Weight Management (TRIM) Multicenter Feasibility Study: a report of early outcomes. Gastroenterology. 2009;136:A-384.

  59. Deviere J, Ojeda Valdes G, Cuevas L, Closset J, Le Moine O, Eisendrath P, et al. Safety, feasibility and weight loss after transoralgastroplasty: first human multicenter study. Surg Endosc. 2008;22:589-98.

  60. Chiellini G, Iaconelli A, Familiari P, Riccioni ME, Castagneto M, Nanni G, et al. Study of the effects of transoralgastroplasty on insulin sensitivity and secretion in obese subjects. Nutr Metab Cardiovasc Dis. 2010;20:202-7.

  61. Sandler BJ, Rumbaut R, Swain CP, Torres G, Morales L, Gonzales L, et al. Human experience with an endoluminal, endoscopic, gastro jejunal bypass sleeve. Surg Endosc. 2011 Sep;25(9):3028-33.

  62. Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen I. A Multicenter, Randomized Efficacy Study of the EndoBarrier Gastrointestinal Liner for Presurgical Weight Loss Prior to Bariatric Surgery. Ann Surg. 2010;251(2):236-43.

  63. Schweitzer M. Endoscopic intraluminal suture plication of the gastric pouch and stoma in postoperative Roux in Y gastric bypass patients. J Laparoendosc Adv Surg Tech A. 2004;14:223-6.

  64. Thompson CC, Slattery J, Bundga ME, Lautz DB. Peroral endoscopic reduction of dilated gastro jejunal anastomosis after Roux in Y gastric bypass: a possible new option for patients with weight regain. Surg Endosc. 2006;20:1744-8.

  65. Coté GA, Edmundowicz SA. Emerging technology: endoluminal treatment of obesity. Gastrointestinal Endoscopy. Nov 2009;70(5):991-9.

  66. Tarnoff M, Shikora S, Lembo A, Gersin K. Chronic in vivo experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model. Surg Endosc. 2008;22:1023-8.

  67. Rodriguez L, Galvao MP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4:55-9.

  68. Tarnoff M, Shikora S, Lembo A. Acute technical feasibility of an endoscopic duodenal-jejunal bypass sleeve in a porcine model: a potentially novel treatment for obesity and type 2 diabetes. Surg Endosc. 2008;22:772-6.

  69. Tarnoff M, Rodríguez L, Escalona A, Ramos A, Neto M, Alamo M, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23:650-6.

  70. Luengas RA. New techniques in gastrointestinal endoscopic surgery. Medwave. 2012;12(8):e5479.

  71. Yáñez MR, Pimentel MF, Awruch PD, Galvao NM, Ibañes AL, Turriel A, et al. Dispositivo endoscópico duodeno yeyunal restrictivo en pacientes obesos mórbidos, experiencia inicial en humanos. Rev Chil Cir. 2010;62(3):234-9.

  72. Gersin KS, Keller JE, Stefanidis D, Simms CS, Abraham DD, Deal SE, et al. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14:275-8.

  73. Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121:885-93.

  74. Arellano JF. Visión global del estado actual de la cirugía bariátrica. Cirujano General. Ene-Mar 2009;31(1):S42-S43.




2020     |     www.medigraphic.com